Cytek Biosciences, Inc.CTKBEarnings & Financial Report
Nasdaq · Health Care · Laboratory Analytical Instruments
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 13.10% | 17.8M | ▲ +2.20pp | 2024-01-23 |
| The Vanguard Group | 8.77% | 11.9M | — | 2024-02-13 |
| NOS. OF ABOVE PERSONS | 7.22% | 9.5M | ▲ +2.02pp | 2024-11-14 |
| Hillhouse Investment Management, Ltd. | 5.10% | 6.7M | — | 2024-11-14 |
| RA Capital Management, L.P. | 4.99% | 6.8M | — | 2023-09-19 |
| HHLR Advisors, Ltd. | 4.90% | 6.7M | — | 2024-02-14 |
| Ming Yan | 4.70% | 6.2M | — | 2024-02-14 |
| Wenbin Jiang | 4.30% | 5.7M | — | 2024-02-14 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-13 | Ming Yan | CHIEF TECHNOLOGY OFFICER | Gift | 1.18M | $0.00 | $0 |
| 2026-03-10 | Philippe Busque | SVP, GLOBAL SALES AND SERVICES | Option exercise | 2.0K | — | — |
| 2026-03-10 | Philippe Busque | SVP, GLOBAL SALES AND SERVICES | Option exercise | 2.9K | — | — |
| 2026-03-10 | Philippe Busque | SVP, GLOBAL SALES AND SERVICES | Option exercise | 4.8K | — | — |
| 2026-03-10 | McCombe William D. | Chief Financial Officer | Option exercise | 6.3K | — | — |
| 2026-03-10 | McCombe William D. | Chief Financial Officer | Option exercise | 17.4K | — | — |
| 2026-03-10 | Wenbin Jiang | PRESIDENT AND CEO | Option exercise | 15.7K | — | — |
| 2026-03-10 | Wenbin Jiang | PRESIDENT AND CEO | Option exercise | 29.5K | — | — |
| 2026-03-10 | Wenbin Jiang | PRESIDENT AND CEO | Option exercise | 38.7K | — | — |
| 2026-03-10 | Valerie Barnett | CHIEF LEGAL OFFICER | Option exercise | 4.9K | — | — |
1–10 of 20
Page 1 / 2